oncology
FDA grants marketing authorisation to DNA test for predisposition to certain cancers
October 2, 2023Research and Development FDA, Invitae, Oncology, cancer testing, oncology
The US Food and Drug Administration (FDA) has granted de novo marketing authorisation to the Invitae Common Hereditary Cancers Panel, …
Kura Oncology shares preclinical data for NSCLC treatment
September 29, 2023Medical Communications Kura Oncology, NSCLC, Oncology, oncology
Kura Oncology has shared positive preclinical data which supports the development of its next-generation farnesyl transferase inhibitor (FTI) KO-2806 in …
Sunbird Bio and Glympse Bio merge for development of protein-based diagnostic technology
August 10, 2023Business Services Glympse Bio, Oncology, Sunbird Bio, merger, oncology
Sunbird Bio has announced that it has completed a merger with Glympse Bio, intending to accelerate the development of both …
BioIVT acquires PrecisionMed for neurology and oncology research
July 21, 2023Sales and Marketing Neurology, Oncology, neurology, oncology
BioIVT has announced that it has acquired PrecisionMed, a leading supplier of high-quality human biological material for genetics, drug discovery …
UK nonprofit National Cancer Research Institute to close
June 27, 2023Medical Communications Cancer, NCRI, National Cancer Research Institute, Oncology, oncology
The National Cancer Research Institute (NCRI) has announced that it is closing after 22 years of advancing cancer research. Established …
XOMA acquires royalty and milestone rights for NPC and pancreatic cancer assets
June 23, 2023Sales and Marketing Cancer, Oncology, Xoma, acquisition, oncology
US-based biotechnology royalty aggregator XOMA has announced that it has gained the royalty and milestone rights for two assets from …
FDA approves Pfizer’s HRR mCRPC drug
June 21, 2023Medical Communications FDA, Oncology, Pfizer, breast cancer, oncology, prostate cancer
US-based pharmaceutical and biotechnology company Pfizer has announced that the US Food and Drug Administration (FDA) has approved its homologous …
GSK receives FDA file acceptance for Jemperli plus chemotherapy for treating endometrial cancer
June 6, 2023Research and Development GSK, Jemperli, Oncology, endometrial cancer, oncology
GSK has announced that the US Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for …
Allogene Therapeutics shares updated ALLO-501/501A phase 1 data in large B-cell lymphoma at ASCO annual meeting
June 5, 2023Research and Development Allogene, LBCL, Oncology, lymphoma, oncology
Allogene Therapeutics has shared updated data from the phase 1 ALPHA/ALPHA2 trials of ALLO-501/501A in patients with relapsed/refractory (r/r) large …
BioInvent and Transgene announce positive phase 1a solid tumour trial data
May 25, 2023Research and Development BioInvent, Oncology, Transgene, clinical trials, oncology, tumours
Sweden-based BioInvent and French Transgene, both biotech companies, have reported positive phase 1a data from a trial studying BT-001 for …
AstraZeneca shares oncology data at ASCO 2023
May 25, 2023Medical Communications ASCO, AstraZeneca, Cancer, Oncology, oncology
AstraZeneca plans to share data from its oncology pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting on …
FDA announces acceptance and priority review of NDA for LUMISIGHT imagining agent for breast cancer
May 23, 2023Research and Development FDA, Lumicell, Oncology, breast cancer, oncology
Lumicell has announced that the US Food and Drug Administration (FDA) has accepted and granted priority review for the New …
Asieris Pharmaceuticals and Uroviu announce strategic collaboration to further develop integrated diagnosis and treatment for bladder cancer
May 18, 2023Research and Development Asieris Pharmaceuticals, Diagnostics, Oncology, Uroviu, bladder cancer, oncology
US-based biopharmaceutical company Asieris Pharmaceuticals and single-use endoscopic platform creator Uroviu have announced that they have entered into a strategic …
RadioMedix and Orano Med complete patient enrolment for neuroendocrine cancer trial
May 16, 2023Medical Communications Oncology, Orano Med, RadioMedix, neuroendocrine cancer, oncology
US-based RadioMedix and French Orano Med, two clinical stage radiopharmaceutical companies, have announced that the last patient has been enrolled …
Gilead acquires XinThera to strengthen pipeline in oncology and inflammation
May 10, 2023Sales and Marketing Gilead, Oncology, XinThera, inflammation, oncology
Gilead Sciences has announced the acquisition of all outstanding shares of XinThera, a privately-owned biotech company based in San Diego, …
Latest content
FibroFind appoints Lee Borthwick as CEO
